Diabetic Retinopathy Is Reshaping the Global Workforce—What You Need to Know

Diabetic retinopathy (DR) occurs when high blood sugar damages the tiny blood vessels in the retina, the light-sensing tissue at the back of the eye. Over time, this damage can lead to vision loss and blindness. Among working-age adults worldwide, it is now the leading cause of preventable blindness and visual impairment—a distinction that reflects both how common diabetes has become and how serious its eye complications can be.

A new study published in the Journal of Diabetes and Metabolic Disorders analyzed global data spanning more than 30 years to understand just how much this complication affects people who are actively working or in their prime earning years.

Researchers examined cases of blindness and visual impairment caused by diabetes from 1990 to 2021 using data from the Global Burden of Disease Study 2021. They measured both how many people were affected and the years of healthy life lost to disability—a metric that captures the true human cost of the condition.

The findings are clear: the global burden of diabetes-related vision loss among the working-age population increased significantly over those three decades. Using statistical models, researchers also projected what this trend might look like through 2050, and the forecast suggests the burden will continue to rise.

When researchers compared Type 1 and Type 2 diabetes, the numbers told a striking story. The number of people with Type 2 diabetes experiencing blindness and visual impairment is much higher than those with Type 1 diabetes. This difference reflects the overall prevalence of the two conditions: Type 2 diabetes affects far more people globally than Type 1.

This does not mean Type 1 diabetes is less serious—retinopathy can develop in people with either type if blood sugar control is not maintained. Rather, it reflects the sheer scale of Type 2 diabetes as a global health challenge.

Across the time period studied, women have consistently experienced a higher burden of diabetes-related blindness and visual impairment than men. Researchers also analyzed disparities based on socioeconomic status, revealing that health inequalities play a significant role in who is most affected by these serious complications.

This finding underscores that access to good diabetes care, regular eye screening, and effective treatment for retinopathy is not equally distributed around the world.

Vision loss from diabetic retinopathy has ripple effects that extend far beyond eye health. For people of working age, blindness and visual impairment can mean job loss, reduced income, and loss of independence. The condition significantly reduces overall quality of life and adds to the total burden of disease caused by diabetes.

The rising trend documented in this study signals an urgent need for better prevention, earlier detection through regular eye exams, and improved access to treatments that can slow or stop retinopathy from progressing. For anyone with diabetes, maintaining good blood sugar control and having regular eye checkups remain among the most powerful tools to protect vision.

Source: Journal of diabetes and metabolic disorders. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.